Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/104194| Title: | Novel biomarker signature predicts sensitivity to PP2A activators in triple negative breast cancer |
| Other Titles: | OFP-13-002 : Novel biomarker signature predicts sensitivity to PP2A activators in triple negative breast cancer |
| Authors: | Baldacchino, Shawn Saliba, Christian Scerri, Christian A. Grech, Godfrey |
| Keywords: | Triple negative breast neoplasms -- Diagnosis Breast -- Cancer -- Diagnosis Biochemical markers -- Diagnostic use Immunosuppressive agents Fingolimod Hydrochloride |
| Issue Date: | 2017 |
| Publisher: | Springer |
| Citation: | Baldacchino, S., Saliba, C., Scerri, C., & Grech, G. (2017). Novel biomarker signature predicts sensitivity to PP2A activators in triple negative breast cancer. Virchows Archiv, 471 (Suppl. 1), S39-S40. |
| Abstract: | Objective: Triple negative breast cancer (TNBC) patients derive little benefit from target-specific therapies due to lack of favourable prognostic targets. The aim of this project was to define biomarkers to measure PP2A complex deregulation in breast cancer, predicting a novel therapeutic class. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/104194 |
| Appears in Collections: | Scholarly Works - FacM&SPat |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Novel biomarker signature predicts sensitivity to PP2A activators in triple negative breast cancer 2017.pdf Restricted Access | 145.43 kB | Adobe PDF | View/Open Request a copy |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.